早产儿肠外营养相关性胆汁淤积症的防治进展

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (343 KB) HTML (34 KB)
输出: BibTeX | EndNote (RIS)

摘要早产儿胆汁淤积的发生率比足月儿明显升高,在极低出生体重儿中其发生率可达18%~24%,其中绝大多数为肠外营养相关性胆汁淤积症(PNAC)。PNAC的预防有个体因素的预防和静脉营养相关的危险因素的预防两大方面。治疗主要包括熊去氧胆酸、S-腺苷蛋氨酸、胆囊收缩素和外科治疗。PNAC如未早期干预,可进一步进展为胆汁淤积性肝硬化、肝功能衰竭。因此,PNAC的早期预防和治疗对于早产儿来说极为重要。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	侯林
	刘捷
	曾超美

关键词 ：早产儿, 肠外营养, 胆汁淤积, 预防, 治疗

收稿日期: 2017-09-29

通讯作者: 曾超美(zengcm@bjmu.edu.cn)

引用本文:

侯林, 刘捷, 曾超美. 早产儿肠外营养相关性胆汁淤积症的防治进展[J]. 中国生育健康杂志, 2018, 29(3): 293-296.

链接本文:

http://cjrh.bjmu.edu.cn/CN/ 或 http://cjrh.bjmu.edu.cn/CN/Y2018/V29/I3/293

1 Alkharfy TM,Ba-Abbad R,Hadi A,et al.Total parenteral nutrition-associated cholestasis and risk factors in preterm infants.Saudi J Gastroentero,2014,20:293-296.
2 Costa S,Maggio L,Sindico P,et al.Preterm small for gestational age infants are not at higher risk for parenteral nutrition-associated cholestasis.J Pediatr,2010,156:575-579.
3 Jolindahel K,Ferretti E,Montiveros C,et al.Parenteral nutrition-induced cholestasis in neonates:where does the problem lie? Gastroenterol Res Pract,2013,11:163632.
4 Christensen RD,Henry E,Wiedmeier SE,et al.Identifying patients,on the first day of life,at high-risk of developing parenteral nutrition-associated liver disease.J Perinatol,2007,27:284-290.
5 Leaf A,Dorling J,Kempley S,et al.Early or delayed enteral feeding for preterm growth-restricted infants:a randomized trial.J Clin Neonatol,2013,129:e1260.
6 陈蓓,苏萍,韩进天,等.极早早产儿早期持续鼻饲输注喂养预防早产儿喂养不耐受.中国医学创新,2012,09:5-7.
7 Bhat V,Fojas M,Saslow JG,et al.Twice-weekly fluconazole prophylaxis in premature infants:Association with cholestasis.Pediatr Int,2011,53:475–479.
8 Choi YY,Yun HJ,Su MC,et al.Gallbladder pseudolithiasis caused by ceftriaxone in young adult.J Korean Surg Soc,2011,81:423-6.
9 Steinbach M,Clark RH,Kelleher AS,et al.Demographic and nutritional factors associated with prolonged cholestatic jaundice in the premature infant.J Perinatol,2008,28:129-135.
10 Lane E,Murray KF.Neonatal Cholestasis.Pediatr Clin N Am,2017,64:621-639.
11 Lee WS,Sokol RJ.Intestinal Microbiota,Lipids,and the Pathogenesis of Intestinal Failure?Associated Liver Disease.J Pediatr,2015,167:519-526.
12 Robinson DT,Ehrenkranz RA.Parenteral nutrition-associated cholestasis in small for gestational age infants.J Pediatr,2008,152:59-62.
13 Gonzalez KW,Weaver KL,Biondo DJ,et al.Cycling parenteral nutrition in a neonatal surgical patient:An argument for increased utilization.J Pediatr Surg Case Rep,2017,16:1-4.
14 Jensen AR,Goldin AB,Koopmeiners JS,et al.The association of cyclic parenteral nutrition and decreased incidence of cholestatic liver disease in patients with gastroschisis.J Pediatr Surg,2009,44:183-9.
15 Nghiem-Rao TH,Cassidy LD,Polzin EM,et al.Risks and Benefits of Prophylactic Cyclic Parenteral Nutrition in Surgical Neonates.Nutr Clin Pract,2013,28:745-752.
16 Fell GL,Cho BS,Pan A,et al.A Comparison of Fish Oil Sources for Parenteral Lipid Emulsions in a Murine Model.Jpen-Parenter Enterl Nutr,2016,41:181-187.
17 Angsten G,Finkel Y,Lucas S,et al.Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.Jpen-Parenter Enter,2012,36:587-595.
18 Sanchez SE,Braun LP,Mercer LD,et al.The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants.J Pediatr Surg,2013,48:573-578.
19 Levit OL,Calkins KL,Gibson LC,et al.Low-Dose Intravenous Soybean Oil Emulsion for Prevention of Cholestasis in Preterm Neonates.Jpen J Parenter Enteral Nutr,2016,40:374-382
20 Rangel SJ,Calkins CM,Cowles RA,et al.Parenteral nutrition-associated cholestasis:an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review.J Pediatr Surg,2012,47:225-40.
21 Spencer AU,Yu S,Tracy TF,et al.Parenteral Nutrition-Associated Cholestasis in Neonates:Multivariate Analysis of the Potential Protective Effect of Taurine.Jpen J Parenter Enteral Nutr,2005,29:337.
22 Kadrofske MM,Parimi PS,Gruca LL,et al.Effect of intravenous amino acids on glutamine and protein kinetics in low-birth-weight preterm infants during the immediate neonatal period.Am J Physiol Endocrinol Metab,2006,290:E622-30.
23 Nayrouz M,Amin S.Cumulative Amount of Intravenous Lipid Intake and Parenteral Nutrition-Associated Cholestasis in Neonates with Gastrointestinal Surgical Disorders.Am J Perinat,2014,31:419-424.
24 Alemmari A,Miller GG,Bertolo RF,et al.Reduced aluminum contamination decreases parenteral nutrition associated liver injury.J Pediatr Surg,2012,47:889-894.
25 Poole RL,Hintz SR,Mackenzie NI,et al.Aluminum exposure from pediatric parenteral nutrition:meeting the new FDA regulation.Jpen J Parenter Enteral Nutr,2008,32:242.
26 Simic D,Milojevic I,Bogicevic D,et al.Preventive effect of ursodeoxycholic acid on parenteral nutrition-associated liver disease in infants.Srp Ark Celok Lek,2014,142:184-188.
27 Thibault M,Mcmahon J,Faubert G,et al.Parenteral nutrition-associated liver disease:a retrospective study of ursodeoxycholic acid use in neonates.J Pediatr Pharmacol,2014,19:42-48.
28 Zhang H,Ning LI,Liu F,et al.S-Adenosyl-L-Methionine prevents total parenteral nutrition-induced cholestasis in rats.Parenteral & Enteral Nutrition,2000.
29 Li N,Zhang H,Wang S,et al.Laboratory investigation and clinical application of S-adenosyl-L-methionine in the treatment of cholestasis after total parenteral nutrition.国际肝胆胰杂志(英文),2002,40:407.
30 李世芳,赵淑艳,张环,等.S-腺苷蛋氨酸对极低出生体重儿胃肠外营养相关性胆汁淤积的防治作用.中国实用医药,2012,07:30-31.
31 慕海峰,郑宇,刘立人.胆囊收缩素对肠外营养期间胆汁淤积预防作用的实验研究.哈尔滨医药,2002,10-11.
32 Teitelbaum DH,Jr TT,Aouthmany MM,et al.Use of cholecystokinin-octapeptide for the prevention of parenteral nutrition-associated cholestasis.Pediatr,2005,115:1332-1340.